Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.
SaaS Adoption
SaaS Adoption indicates the level of adoption by this company of software as a service services.
Cloud Adoption
Cloud Adoption indicates the level of adoption by this company of cloud services.
IT Footprint
IT Footprint gives a relative indication of how much IT services this company consumes.
IT Spend
IT Spend shows roughly how much this client spends on IT per year in USD.
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
Lundbeck uses 5 different technologies from 163 different vendors. They have above average use of several technologies including DocuSign, Microsoft Office 365 and SAP Business Planning and Consolidation.
Lundbeck uses products from 105 different product categories. They are particularly heavy users of products in Business Intelligence, Enterprise Resource Planning (ERP), and Software Frameworks.
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
| Technology | Category | Vendor | Usage |
|---|---|---|---|
| Simulink | Computer-aided Design & Engineering | The MathWorks, Inc | ![]() |
| SAP S/4HANA | Enterprise Resource Planning (ERP) | SAP | ![]() |
| SuccessFactors | Enterprise HR Management | SAP | ![]() |
| Microsoft power BI | Business Intelligence | Microsoft Corporation | ![]() |
| Python | Programming Languages | Python Software Foundation | ![]() |
What other companies use Simulink?
Who are the biggest users of Enterprise Resource Planning (ERP)?
What countries, industries, and company sizes are most likely to use SuccessFactors?